USPTO serial 79212487
POLYPHOR
Reviewed by CopyMark Law Group
Reg. 5393654Status 709
- Filing date
- Status date
- Registration date
- Feb 6, 2018
- Examiner
- DANG, PETER T
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with POLYPHOR?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Scott D. Woldow
Scott D. Woldow Smith, Gambrell, Russell, LLP1055 Thomas Jefferson St. NW, Suite 400Washington, DC 20007UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemicals used in industry, science, agriculture, horticulture and silviculture, except fungicides, herbicides, insecticides and parasiticides; unprocessed artificial resins, unprocessed plastics; soil fertilizers; chemical substances for preserving foodstuffs, namely, food preservatives; adhesives used in industry | SECTION 71 - CANCELLED | — |
| 005 | Pharmaceutical, veterinary and sanitary products, namely, Pharmaceutical anti-allergic preparations and substances, Pharmaceutical for the treatment of erectile dysfunction, Pharmaceutical preparations, namely, anticoagulants, Pharmaceutical preparations, namely, antidepressants, Pharmaceutical preparations, namely, appetite suppressants, Pharmaceutical preparations for use in chemotherapy, Pharmaceutical preparation for the treatment of gout, Pharmaceutical preparations for the treatment of heart rhythm disorders, Pharmaceutical preparations for the treatment of stem cell mobilization, Pharmaceutical preparations for the treatment of infectious diseases, Pharmaceutical preparations acting on the central nervous system, Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases, Pharmaceutical preparations for animal skincare, Pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension, Pharmaceutical preparations for ocular or intraocular surgery, Pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis, Pharmaceutical preparations for treating allergic rhinitis and asthma, Pharmaceutical preparations for treating diabetes, Pharmaceutical preparations for treating skin disorders, Pharmaceutical preparations for use in dermatology, Pharmaceutical preparations for wounds, Pharmaceutical preparations for use in urology, Pharmaceutical preparations, namely, a blood clotting aid and delivery system for use in human and veterinary medicine, Pharmaceutical products and preparations against dry skin caused by pregnancy, Pharmaceutical products and preparations for chloasma, Pharmaceutical products and preparations for hydrating the skin during pregnancy, Pharmaceutical products and preparations for pregnancy blemishes, Pharmaceutical products and preparations for preventing skin blemishes during pregnancy, Pharmaceutical products and preparations to prevent stretch marks, Pharmaceutical products and preparations to prevent swelling in the legs, Pharmaceutical products for ophthalmological use, Pharmaceutical products for skin care for animals, Pharmaceutical products for the treatment of bone diseases, Pharmaceutical products for the treatment of viral and infectious diseases and for the treatment of cancer, Pharmaceutical products for treating respiratory diseases and asthma, Pharmaceutical skin lotions, Pharmaceutical solutions used in dialysis, Pharmaceuticals, namely, antihelmintics, Pharmaceuticals, namely, inducers of erections, Pharmaceuticals, namely, lipid lowering agents, Pharmaceuticals, namely, psychotropics, Pharmaceuticals, namely, anti-infectives; Veterinary preparations, namely, pain relief medication, veterinary preparations for the treatment of intestinal bacteria, Veterinary vaccine for horses, Veterinary vaccines; sanitary preparations for medical purposes; disinfectants; products for destroying vermin, namely, vermin destroying preparations; fungicides, herbicides | SECTION 71 - CANCELLED | — |
| 042 | Research, consultancy, and product development based on internal and customer data in the field chemistry regarding chemicals and resins; Planning of information technology systems for others based on internal and customer data in the field chemistry for researching chemicals and resins | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Polyphor AG
- Other trademarks owned by Polyphor AG
- Other trademarks owned by Polyphor AG
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 042
- Similar marks named POLYPHOR
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 22, 2025 | INNT | TOTAL INVALIDATION PROCESSED BY THE IB | — |
| Aug 7, 2025 | INTS | TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | — |
| Aug 6, 2025 | INPC | INVALIDATION PROCESSED | — |
| Apr 23, 2025 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Aug 23, 2024 | C71T | CANCELLED SECTION 71 | — |
| Feb 6, 2023 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Oct 29, 2022 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| May 7, 2022 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jan 24, 2019 | RNWL | INTERNATIONAL REGISTRATION RENEWED | — |
| Jul 19, 2018 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jun 22, 2018 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| May 14, 2018 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| May 14, 2018 | FIMP | FINAL DISPOSITION PROCESSED | — |
| May 6, 2018 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Feb 6, 2018 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jan 22, 2018 | LIME | LIMITATION FROM THE IB EXAMINED AND ENTERED | — |
| Nov 24, 2017 | LIMG | LIMITATION OF GOODS RECEIVED FROM IB | — |
| Nov 21, 2017 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Nov 21, 2017 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Nov 1, 2017 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Oct 2, 2017 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 22, 2017 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 22, 2017 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 22, 2017 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 11, 2017 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jul 27, 2017 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jul 27, 2017 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jul 25, 2017 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jul 21, 2017 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jul 20, 2017 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 19, 2017 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Jul 19, 2017 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 19, 2017 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 14, 2017 | LIMI | LIMITATION FROM ORIGINAL APPLICATION ENTERED | — |
| Jul 13, 2017 | SDRC | SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB | — |